MiMedx Common Stock vs Short Long Term Debt Total Analysis

MDXG Stock

USD 9.22 0.16 1.77%

MiMedx financial indicator trend analysis is infinitely more than just investigating MiMedx Group recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MiMedx Group is a good investment. Please check the relationship between MiMedx Common Stock and its Short Long Term Debt Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Common Stock vs Short Long Term Debt Total

Common Stock vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MiMedx Group Common Stock account and Short Long Term Debt Total. At this time, the significance of the direction appears to have strong relationship.

The correlation between MiMedx's Common Stock and Short Long Term Debt Total is 0.71. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of MiMedx Group, assuming nothing else is changed. The correlation between historical values of MiMedx's Common Stock and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of MiMedx Group are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Common Stock i.e., MiMedx's Common Stock and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Common Stock

Short Long Term Debt Total

Most indicators from MiMedx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MiMedx Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

At this time, MiMedx's Enterprise Value Multiple is most likely to increase significantly in the upcoming years. The MiMedx's current Enterprise Value is estimated to increase to about 1 B, while Selling General Administrative is projected to decrease to roughly 123.2 M.

	2021	2023	2024 (projected)
Non Recurring	53K	47.7K	45.3K
Reconciled Depreciation	5.2M	3.6M	4.6M

Non Recurring Reconciled Depreciation

MiMedx fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant And Equipment Net	Good Will	Property Plant And Equipment Gross	Short Term Debt	Net Receivables
Total Assets		0.45	0.68	0.61	0.49	-0.61	-0.57	0.56	0.88	0.81	-0.04	0.88	0.54	0.72	0.51	0.6	0.83	0.64	0.97	-0.01	0.74	0.6	0.69	0.87	0.17	0.8
Short Long Term Debt Total	0.45		0.59	0.63	0.37	-0.81	-0.06	0.61	0.36	0.44	0.49	0.38	0.69	0.72	0.01	0.4	0.38	0.22	0.41	0.22	0.71	0.7	0.49	0.32	0.32	0.25
Other Current Liab	0.68	0.59		0.92	0.09	-0.6	-0.36	0.85	0.61	0.66	0.44	0.6	0.6	0.63	0.44	0.73	0.39	0.69	0.62	0.0	0.66	0.91	0.91	0.63	0.59	0.32
Total Current Liabilities	0.61	0.63	0.92		0.1	-0.64	-0.31	0.96	0.54	0.65	0.55	0.53	0.6	0.61	0.3	0.67	0.37	0.6	0.53	0.02	0.65	0.97	0.91	0.65	0.72	0.19
Total Stockholder Equity	0.49	0.37	0.09	0.1		-0.38	-0.09	0.21	0.16	0.66	0.08	0.17	0.21	0.45	-0.46	-0.21	0.77	-0.35	0.37	0.41	0.42	0.08	0.03	0.56	-0.07	0.48
Net Debt	-0.61	-0.81	-0.6	-0.64	-0.38		0.51	-0.58	-0.68	-0.45	-0.29	-0.69	-0.62	-0.64	-0.15	-0.35	-0.62	-0.35	-0.61	-0.05	-0.68	-0.67	-0.49	-0.52	-0.28	-0.31
Retained Earnings	-0.57	-0.06	-0.36	-0.31	-0.09	0.51		-0.2	-0.77	-0.34	0.13	-0.76	-0.37	-0.43	-0.48	-0.36	-0.65	-0.51	-0.61	0.25	-0.49	-0.27	-0.36	-0.55	-0.16	-0.29
Accounts Payable	0.56	0.61	0.85	0.96	0.21	-0.58	-0.2		0.41	0.68	0.55	0.4	0.59	0.58	0.13	0.53	0.39	0.44	0.46	0.17	0.6	0.92	0.84	0.65	0.73	0.17
Cash	0.88	0.36	0.61	0.54	0.16	-0.68	-0.77	0.41		0.53	-0.13	1.0	0.48	0.6	0.71	0.68	0.69	0.78	0.93	-0.32	0.65	0.53	0.61	0.73	0.17	0.61
Non Current Assets Total	0.81	0.44	0.66	0.65	0.66	-0.45	-0.34	0.68	0.53		0.4	0.52	0.51	0.67	0.08	0.48	0.78	0.29	0.65	0.21	0.68	0.63	0.71	0.88	0.49	0.49
Non Currrent Assets Other	-0.04	0.49	0.44	0.55	0.08	-0.29	0.13	0.55	-0.13	0.4		-0.13	0.32	0.25	-0.32	0.32	0.0	-0.08	-0.21	0.06	0.24	0.58	0.43	0.2	0.84	-0.48
Cash And Short Term Investments	0.88	0.38	0.6	0.53	0.17	-0.69	-0.76	0.4	1.0	0.52	-0.13		0.49	0.61	0.7	0.67	0.7	0.77	0.93	-0.31	0.66	0.52	0.59	0.72	0.15	0.62
Common Stock Total Equity	0.54	0.69	0.6	0.6	0.21	-0.62	-0.37	0.59	0.48	0.51	0.32	0.49		0.88	0.27	0.5	0.48	0.43	0.49	0.4	0.86	0.6	0.57	0.35	0.37	0.3
Common Stock Shares Outstanding	0.72	0.72	0.63	0.61	0.45	-0.64	-0.43	0.58	0.6	0.67	0.25	0.61	0.88		0.26	0.56	0.69	0.43	0.66	0.23	0.99	0.58	0.62	0.57	0.3	0.49
Non Current Liabilities Total	0.51	0.01	0.44	0.3	-0.46	-0.15	-0.48	0.13	0.71	0.08	-0.32	0.7	0.27	0.26		0.73	0.07	0.94	0.63	-0.42	0.3	0.33	0.5	0.23	-0.01	0.44
Other Current Assets	0.6	0.4	0.73	0.67	-0.21	-0.35	-0.36	0.53	0.68	0.48	0.32	0.67	0.5	0.56	0.73		0.23	0.85	0.59	-0.44	0.59	0.69	0.79	0.52	0.55	0.24
Other Stockholder Equity	0.83	0.38	0.39	0.37	0.77	-0.62	-0.65	0.39	0.69	0.78	0.0	0.7	0.48	0.69	0.07	0.23		0.19	0.76	0.12	0.71	0.33	0.38	0.84	0.13	0.61
Total Liab	0.64	0.22	0.69	0.6	-0.35	-0.35	-0.51	0.44	0.78	0.29	-0.08	0.77	0.43	0.43	0.94	0.85	0.19		0.71	-0.35	0.47	0.61	0.74	0.42	0.24	0.44
Total Current Assets	0.97	0.41	0.62	0.53	0.37	-0.61	-0.61	0.46	0.93	0.65	-0.21	0.93	0.49	0.66	0.63	0.59	0.76	0.71		-0.1	0.68	0.53	0.61	0.77	0.02	0.84
Intangible Assets	-0.01	0.22	0.0	0.02	0.41	-0.05	0.25	0.17	-0.32	0.21	0.06	-0.31	0.4	0.23	-0.42	-0.44	0.12	-0.35	-0.1		0.16	0.02	-0.01	-0.13	-0.14	0.16
Common Stock	0.74	0.71	0.66	0.65	0.42	-0.68	-0.49	0.6	0.65	0.68	0.24	0.66	0.86	0.99	0.3	0.59	0.71	0.47	0.68	0.16		0.61	0.65	0.61	0.34	0.47
Property Plant And Equipment Net	0.6	0.7	0.91	0.97	0.08	-0.67	-0.27	0.92	0.53	0.63	0.58	0.52	0.6	0.58	0.33	0.69	0.33	0.61	0.53	0.02	0.61		0.88	0.58	0.67	0.21
Good Will	0.69	0.49	0.91	0.91	0.03	-0.49	-0.36	0.84	0.61	0.71	0.43	0.59	0.57	0.62	0.5	0.79	0.38	0.74	0.61	-0.01	0.65	0.88		0.67	0.65	0.28
Property Plant And Equipment Gross	0.87	0.32	0.63	0.65	0.56	-0.52	-0.55	0.65	0.73	0.88	0.2	0.72	0.35	0.57	0.23	0.52	0.84	0.42	0.77	-0.13	0.61	0.58	0.67		0.46	0.5
Short Term Debt	0.17	0.32	0.59	0.72	-0.07	-0.28	-0.16	0.73	0.17	0.49	0.84	0.15	0.37	0.3	-0.01	0.55	0.13	0.24	0.02	-0.14	0.34	0.67	0.65	0.46		-0.41
Net Receivables	0.8	0.25	0.32	0.19	0.48	-0.31	-0.29	0.17	0.61	0.49	-0.48	0.62	0.3	0.49	0.44	0.24	0.61	0.44	0.84	0.16	0.47	0.21	0.28	0.5	-0.41

Click cells to compare fundamentals

MiMedx Account Relationship Matchups

MiMedx fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	56.7M	50.4M	35.0M	35.1M	37.0M	22.9M
Common Stock Shares Outstanding	105.6M	108.3M	110.4M	112.9M	146.0M	94.7M
Other Liab	621K	3.8M	4.9M	2.3M	2.1M	2.6M
Net Tangible Assets	6.6M	91.4M	(25.3M)	(43.8M)	(39.4M)	(37.5M)
Other Assets	443K	375K	186K	148K	133.2K	126.5K
Property Plant Equipment	15.7M	11.4M	13.9M	11.3M	12.9M	10.9M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:

How To Invest In MiMedx

Details

Is MiMedx Stock a good investment?

Details

What is MiMedx's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.1)

Earnings Share

0.57

Revenue Per Share

2.447

Quarterly Revenue Growth

0.029

Return On Assets

0.1838

The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MiMedx Common Stock vs Short Long Term Debt Total Analysis

Common Stock vs Short Long Term Debt Total

Common Stock vs Short Long Term Debt Total Correlation Analysis

Correlation Coefficient

Common Stock

Short Long Term Debt Total

MiMedx fundamental ratios Correlations

MiMedx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MiMedx fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 0.99	Common Stock Shares Outstanding
Total Current Assets	+ 0.97	Total Assets
Property Plant And Equipment Net	+ 0.97	Total Current Liabilities
Accounts Payable	+ 0.96	Total Current Liabilities
Total Liab	+ 0.94	Non Current Liabilities Total

Net Debt	- 0.81	Short Long Term Debt Total
Cash	- 0.77	Retained Earnings
Cash And Short Term Investments	- 0.76	Retained Earnings
Cash And Short Term Investments	- 0.69	Net Debt
Common Stock	- 0.68	Net Debt
Cash	- 0.68	Net Debt